obinutuzumab - CISMeF

Preferred Label : obinutuzumab;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details

Origin ID

M0582537;

UMLS CUI

C2742503;

CISMeF manual mappings
- Obinutuzumab (substance) [SNOMED CT concept]
MeSH narrower concept(s)
- GA 101 [MeSH concept]
- R 7159 [MeSH concept]
- RO 5072759 [MeSH concept]
- afutuzumab [MeSH concept]
- gazyva [MeSH concept]
Related record
- obinutuzumab [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing obinutuzumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Obinutuzumab [NCIt concept]
- Obinutuzumab (substance) [SNOMED CT concept]
- Product containing obinutuzumab (medicinal product) [SNOMED CT concept]
- obinutuzumab [ATC Code]
Validated automatic mappings to BTNT
- obinutuzumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients